iSpecimen Inc. (ISPC) Return on equity 2021–2025
iSpecimen Inc. (ISPC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-339.6%FY2025 · since FY2021: -30.1% → -339.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -339.6% | +37.9 pp |
| FY2024 | -377.5% | -263.5 pp |
| FY2023 | -113.9% | -63.5 pp |
| FY2022 | -50.4% | -20.4 pp |
| FY2021 | -30.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ISPC financial trends
ISPC RevenueISPC Net incomeISPC Net marginISPC Gross profitISPC Gross marginISPC Operating incomeISPC Operating marginISPC Operating cash flowISPC Free cash flowISPC Capital expendituresISPC Stock buybacksISPC Dividends paidISPC Total assetsISPC Total liabilitiesISPC Shareholders’ equityISPC overview →